112 related articles for article (PubMed ID: 22116018)
41. The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study.
Mu Y; Wang H; He T; Xu L
J Immunol Res; 2022; 2022():7581799. PubMed ID: 36285181
[TBL] [Abstract][Full Text] [Related]
42. Role of Nutritional Status in the Treatment Outcome for Esophageal Squamous Cell Carcinoma.
Chen MF; Hsieh CC; Chen PT; Lu MS
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578883
[TBL] [Abstract][Full Text] [Related]
43. Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial.
Pöttgen C; Gkika E; Stahl M; Abu Jawad J; Gauler T; Kasper S; Trarbach T; Herrmann K; Lehmann N; Jöckel KH; Lax H; Stuschke M
Radiat Oncol; 2021 Mar; 16(1):59. PubMed ID: 33757534
[TBL] [Abstract][Full Text] [Related]
44. Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity.
Ristau J; Thiel M; Katayama S; Schlampp I; Lang K; Häfner MF; Herfarth K; Debus J; Koerber SA
Radiat Oncol; 2021 Feb; 16(1):23. PubMed ID: 33522923
[TBL] [Abstract][Full Text] [Related]
45. LncRNA MAGI2-AS3 Overexpression Sensitizes Esophageal Cancer Cells to Irradiation Through Down-Regulation of HOXB7
Cheng W; Shi X; Lin M; Yao Q; Ma J; Li J
Front Cell Dev Biol; 2020; 8():552822. PubMed ID: 33330444
[TBL] [Abstract][Full Text] [Related]
46. Dose-Dependent Radiation-Induced Myocardial Damage in Esophageal Cancer Treated With Chemoradiotherapy: A Prospective Cardiac Magnetic Resonance Imaging Study.
Umezawa R; Kadoya N; Ota H; Nakajima Y; Saito M; Takagi H; Takanami K; Takahashi N; Ishikawa Y; Yamamoto T; Matsushita H; Takeda K; Takase K; Jingu K
Adv Radiat Oncol; 2020; 5(6):1170-1178. PubMed ID: 33305078
[TBL] [Abstract][Full Text] [Related]
47. Immunotherapy in gastroesophageal cancers: Current state and future directions.
Shaikh H; Kamran A; Monga DK
J Oncol Pharm Pract; 2021 Mar; 27(2):395-404. PubMed ID: 33050805
[TBL] [Abstract][Full Text] [Related]
48. Identification of most influential co-occurring gene suites for gastrointestinal cancer using biomedical literature mining and graph-based influence maximization.
Wang CCN; Jin J; Chang JG; Hayakawa M; Kitazawa A; Tsai JJP; Sheu PC
BMC Med Inform Decis Mak; 2020 Sep; 20(1):208. PubMed ID: 32883271
[TBL] [Abstract][Full Text] [Related]
49. Baseline FDG Uptake And Peripheral Lymphocyte-Monocyte Ratio For Predicting Chemoradiotherapy Response In Patients With Esophageal Squamous Cell Carcinoma.
Wang C; Zhao K; Huang Y; Ma L; Song Y; Li M
Cancer Manag Res; 2019; 11():9085-9093. PubMed ID: 31749632
[TBL] [Abstract][Full Text] [Related]
50. Concurrent liposomal paclitaxel and cisplatin chemotherapy improved outcomes for locally advanced esophageal squamous cell carcinoma treated with intensity-modulated radiotherapy.
Liu S; Ren SN; Ding WX; Ge XL; Cao YD; Zhang S; Zhen FX; Sun XC
Ann Transl Med; 2019 Jul; 7(14):331. PubMed ID: 31475201
[TBL] [Abstract][Full Text] [Related]
51. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.
Sun Y; Zhang XL; Mao QF; Liu YH; Kong L; Li MH
Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693
[TBL] [Abstract][Full Text] [Related]
52. Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of
Li X; Hong X; Gao X; Gu X; Xiong W; Zhao J; Yu H; Cui M; Xie M; Bai Y; Sun S
Cancer Manag Res; 2018; 10():3149-3158. PubMed ID: 30214307
[TBL] [Abstract][Full Text] [Related]
53. Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study.
Kauppila JH; Mattsson F; Brusselaers N; Lagergren J
BMJ Open; 2018 May; 8(5):e021495. PubMed ID: 29748347
[TBL] [Abstract][Full Text] [Related]
54. Surveillance or resection after chemoradiation in esophageal cancer.
Park IH; Kim JY
Ann Transl Med; 2018 Feb; 6(4):82. PubMed ID: 29666805
[TBL] [Abstract][Full Text] [Related]
55. Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: A prospective randomized study.
Nayan N; Bhattacharyya M; Jagtap VK; Kalita AK; Sunku R; Roy PS
South Asian J Cancer; 2018; 7(1):27-30. PubMed ID: 29600230
[TBL] [Abstract][Full Text] [Related]
56. Radiotherapy for esophageal carcinoma: dose, response and survival.
Luo Y; Mao Q; Wang X; Yu J; Li M
Cancer Manag Res; 2018; 10():13-21. PubMed ID: 29343986
[TBL] [Abstract][Full Text] [Related]
57. Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Deng Y; Bian C; Tao H; Zhang H
Oncotarget; 2017 Oct; 8(45):79662-79669. PubMed ID: 29108346
[TBL] [Abstract][Full Text] [Related]
58. Definitive chemoradiotherapy.
Stahl M; Budach W
J Thorac Dis; 2017 Jul; 9(Suppl 8):S792-S798. PubMed ID: 28815076
[TBL] [Abstract][Full Text] [Related]
59. Interventional Therapy of Esophageal Cancer.
Mao A
Gastrointest Tumors; 2016 Oct; 3(2):59-68. PubMed ID: 27904858
[TBL] [Abstract][Full Text] [Related]
60. Radiation field size and dose determine oncologic outcome in esophageal cancer.
Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A
World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
